The protein encoded by this gene is a transcriptional activator that plays an important role in lymphocyte differentiation. This gene is expressed predominantly in T-cells. The encoded protein can bind an enhancer element and activate the CD3E gene, and it also may repress the CTNNB1 and TCF7L2 genes through a feedback mechanism. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011].
Zambanini, Nordin, Jonasson, Pagella, Cantù: "A new cut&run low volume-urea (LoV-U) protocol optimized for transcriptional co-factors uncovers Wnt/b-catenin tissue-specific genomic targets." in: Development (Cambridge, England), (2022) (PubMed).
Smit, Baas, Kuipers, Korswagen, van de Wetering, Clevers: "Wnt activates the Tak1/Nemo-like kinase pathway." in: The Journal of biological chemistry, Vol. 279, Issue 17, pp. 17232-40, (2004) (PubMed).
Noble, White, Lazzeroni, Valdes, Mirel, Reynolds, Grupe, Aud, Peltz, Erlich: "A polymorphism in the TCF7 gene, C883A, is associated with type 1 diabetes." in: Diabetes, Vol. 52, Issue 6, pp. 1579-82, (2003) (PubMed).
Ioannidis, Kunz, Tanamachi, Scarpellino, Held: "Initiation and limitation of Ly-49A NK cell receptor acquisition by T cell factor-1." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 171, Issue 2, pp. 769-75, (2003) (PubMed).